Cargando…

p53-dependent c-Fos expression is a marker but not executor for motor neuron death in spinal muscular atrophy mouse models

The activation of the p53 pathway has been associated with neuronal degeneration in different neurological disorders, including spinal muscular atrophy (SMA) where aberrant expression of p53 drives selective death of motor neurons destined to degenerate. Since direct p53 inhibition is an unsound the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buettner, Jannik M., Sowoidnich, Leonie, Gerstner, Florian, Blanco-Redondo, Beatriz, Hallermann, Stefan, Simon, Christian M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676941/ https://www.ncbi.nlm.nih.gov/pubmed/36419936 http://dx.doi.org/10.3389/fncel.2022.1038276

Ejemplares similares

Central synaptopathy is the most conserved feature of motor circuit pathology across spinal muscular atrophy mouse models
por: Buettner, Jannik M., et al.
Publicado: (2021)

Plant Executor Genes
por: Ji, Zhiyuan, et al.
Publicado: (2022)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2018)

The gasdermin-D pore: Executor of pyroptotic cell death
por: Rühl, Sebastian, et al.
Publicado: (2016)

Spinal muscular atrophy patient-derived motor neurons exhibit hyperexcitability
por: Liu, Huisheng, et al.
Publicado: (2015)

Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy
por: Teoh, Hooi Ling, et al.
Publicado: (2017)

TAL effectors and the executor R genes
por: Zhang, Junli, et al.
Publicado: (2015)

The Many Faces of MLKL, the Executor of Necroptosis
por: Martinez-Osorio, Veronica, et al.
Publicado: (2023)

Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent
por: Wu, Chia-Yen, et al.
Publicado: (2009)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Laser microscopy acquisition and analysis of premotor synapses in the murine spinal cord
por: Buettner, Jannik M., et al.
Publicado: (2022)

Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen
por: Kariyawasam, Didu, et al.
Publicado: (2021)

Different trajectories in upper limb and gross motor function in spinal muscular atrophy
por: Coratti, Giorgia, et al.
Publicado: (2021)

Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy
por: Schmitt, Linda-Isabell, et al.
Publicado: (2023)

Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity
por: Hay, Zachary L. Z., et al.
Publicado: (2022)

Micro-Executor of Natural Products in Metabolic Diseases
por: Liu, Jinxin, et al.
Publicado: (2023)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Onasemnogene abeparvovec for spinal muscular atrophy
Publicado: (2022)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

Editorial: Advances in spinal muscular atrophy
por: Sun, Jianli
Publicado: (2023)

Plastin 3 rescues cell surface translocation and activation of TrkB in spinal muscular atrophy
por: Hennlein, Luisa, et al.
Publicado: (2023)

First Use of Non-Invasive Spinal Cord Stimulation in Motor Rehabilitation of Children with Spinal Muscular Atrophy
por: Novikov, Anton, et al.
Publicado: (2023)

Utility of Survival Motor Neuron ELISA for Spinal Muscular Atrophy Clinical and Preclinical Analyses
por: Kobayashi, Dione T., et al.
Publicado: (2011)

Cell cycle inhibitors protect motor neurons in an organoid model of Spinal Muscular Atrophy
por: Hor, Jin Hui, et al.
Publicado: (2018)

Modeling the phenotype of spinal muscular atrophy by the direct conversion of human fibroblasts to motor neurons
por: Zhang, Qi-Jie, et al.
Publicado: (2017)

Spinal Muscular Atrophy: The Use of Functional Motor Scales in the Era of Disease-Modifying Treatment
por: Pierzchlewicz, Katarzyna, et al.
Publicado: (2021)

Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy
por: Comley, Laura H, et al.
Publicado: (2022)

Dysregulation of Mdm2 and Mdm4 alternative splicing underlies motor neuron death in spinal muscular atrophy
por: Van Alstyne, Meaghan, et al.
Publicado: (2018)

Stasimon Contributes to the Loss of Sensory Synapses and Motor Neuron Death in a Mouse Model of Spinal Muscular Atrophy
por: Simon, Christian M., et al.
Publicado: (2019)

Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy
por: Lusakowska, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e2g8s4k1m3ppe4herc25ri2dnl